SCHEMBL6401807

SCHEMBL6401807

COc1ccc2c(c1)C[C@H](OS(=O)(=O)c1ccc(C)cc1)CC2

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 6/20 0.50
DRD3 P35462 6/20 0.50
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
ACHE P22303 3/20 0.47
CYP2D6 P10635 1/20 0.47
DRD4 P21917 2/20 0.46
MTNR1A P48039 1/20 0.46
MTNR1B P49286 1/20 0.46
HTR6 P50406 1/20 0.43
CYP19A1 P11511 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41
PDE4D Q08499 1/20 0.41
NAAA Q02083 1/20 0.40
MAPT P10636 1/20 0.40
FKBP1A P62942 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766442 0.93 CYP2D6 (0.45) DRD2DRD3CA1CA2ACHE
SCHEMBL8765272 0.93 CYP2D6 (0.45) DRD2DRD3CA1CA2ACHE
SCHEMBL8765278 0.93 CYP2D6 (0.45) DRD2DRD3CA1CA2ACHE
SCHEMBL9630809 0.81 CYP19A1 (0.52) DRD2DRD3CA1CA2ACHE
SCHEMBL6405616 0.81 DRD2 (0.57) DRD2DRD3CA1CA2ACHE
SCHEMBL6406186 0.80 PRMT5 (0.47) DRD2DRD3CA1CA2ACHE
SCHEMBL6406189 0.80 PRMT5 (0.47) DRD2DRD3CA1CA2ACHE
SCHEMBL7402536 0.78 HTR1D (0.57) CYP2D6HTR6MAPT
SCHEMBL4225647 0.77 CYP19A1 (0.47) DRD2DRD3CA1CA2ACHE
SCHEMBL7296513 0.77 CYP19A1 (0.52) DRD2DRD3CA1CA2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153408-A1 7-substituted-2-tetralone or bisulfite adduct is reduced microorganism (Candida) to optically active 7-substituted-2-tetralol;sulfonyl group is introduced to hydroxy group to form optically active 7-substituted-2-sulfonyloxytetralin; nitrogen substituent is introduced via ammonia; industrial scale KANEKA CORPORATION (JP) 2005-07-14 US disclosed
EP-1457570-A1 PROCESS FOR PREPARATION OF 2-AMINOTETRALIN DERIVATIVES AND INTERMEDIATES THEREOF KANEKA CORPORATION (JP) 2004-09-15 EP disclosed